88 related articles for article (PubMed ID: 10644942)
1. Identification of exon-deleted progesterone receptor mRNAs in human uterine endometrial cancers.
Misao R; Nakanishi Y; Sun W; Iwagaki S; Fujimoto J; Tamaya T
Oncology; 2000; 58(1):60-5. PubMed ID: 10644942
[TBL] [Abstract][Full Text] [Related]
2. Identification of various exon-deleted progesterone receptor mRNAs in human endometrium and ovarian endometriosis.
Misao R; Sun WS; Iwagaki S; Fujimoto J; Tamaya T
Biochem Biophys Res Commun; 1998 Nov; 252(2):302-6. PubMed ID: 9826524
[TBL] [Abstract][Full Text] [Related]
3. Variant progesterone receptor mRNAs are co-expressed with the wild-type progesterone receptor mRNA in human endometrium during all phases of the menstrual cycle.
Marshburn PB; Zhang J; Bahrani-Mostafavi Z; Matthews ML; White J; Hurst BS
Mol Hum Reprod; 2005 Nov; 11(11):809-15. PubMed ID: 16339776
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor mRNA variant containing novel exon insertions between exon 4 and exon 5 in human uterine endometrium.
Yamanaka T; Hirata S; Shoda T; Hoshi K
Endocr J; 2002 Aug; 49(4):473-82. PubMed ID: 12402980
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues.
Leygue E; Dotzlaw H; Watson PH; Murphy LC
Br J Cancer; 1999 May; 80(3-4):379-82. PubMed ID: 10408841
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue.
Leygue E; Dotzlaw H; Watson PH; Murphy LC
Biochem Biophys Res Commun; 1996 Nov; 228(1):63-8. PubMed ID: 8912636
[TBL] [Abstract][Full Text] [Related]
7. Variant estrogen and progesterone receptor messages in human vascular smooth muscle.
Hodges YK; Richer JK; Horwitz KB; Horwitz LD
Circulation; 1999 May; 99(20):2688-93. PubMed ID: 10338464
[TBL] [Abstract][Full Text] [Related]
8. Novel alternatively spliced variant with a deletion of 52 BP in exon 6 of the progesterone receptor gene is observed frequently in breast cancer tissues.
Hisatomi H; Kohno N; Wakita K; Nagao K; Hirata H; Hikiji K; Harada S
Int J Cancer; 2003 Jun; 105(2):182-5. PubMed ID: 12673676
[TBL] [Abstract][Full Text] [Related]
9. Expression of sex hormone-binding globulin exon 7 splicing variant mRNA in secondary spreading lesions of gynecological cancers.
Misao R; Iwagaki S; Fujimoto J; Nakanishi Y; Sun WS; Tamaya T
J Steroid Biochem Mol Biol; 1999 Feb; 68(3-4):103-9. PubMed ID: 10369407
[TBL] [Abstract][Full Text] [Related]
10. Clinical implication of expression of progesterone receptor form A and B mRNAs in secondary spreading of gynecologic cancers.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):449-54. PubMed ID: 9449248
[TBL] [Abstract][Full Text] [Related]
11. Expression of sex hormone-binding globulin exon VII splicing variant messenger RNA in human uterine endometrial cancers.
Misao R; Nakanishi Y; Fujimoto J; Tamaya T
Cancer Res; 1997 Dec; 57(24):5579-83. PubMed ID: 9407970
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer.
Leygue E; Huang A; Murphy LC; Watson PH
Cancer Res; 1996 Oct; 56(19):4324-7. PubMed ID: 8813116
[TBL] [Abstract][Full Text] [Related]
13. Novel isoforms of the mRNA for human female sex steroid hormone receptors.
Hirata S; Shoda T; Kato J; Hoshi K
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):25-30. PubMed ID: 12650698
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor variants in normal human mammary tissue.
Leygue ER; Watson PH; Murphy LC
J Natl Cancer Inst; 1996 Mar; 88(5):284-90. PubMed ID: 8614007
[TBL] [Abstract][Full Text] [Related]
15. Expression of a novel splicing variant deleting exons 4 and 6 of the progesterone receptor gene is a rare event in breast cancer.
Nagao K; Kohno N; Wakita K; Hikiji K; Yamamoto S; Hirata H; Hisatomi H
Oncol Rep; 2003; 10(2):305-8. PubMed ID: 12579263
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines.
Xiong Y; Dowdy SC; Gonzalez Bosquet J; Zhao Y; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Oct; 99(1):135-41. PubMed ID: 16024066
[TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen receptor beta exon-deleted variant mRNAs in ovary and uterine endometrium.
Fujimoto J; Sun WS; Misao R; Sakaguchi H; Aoki I; Toyoki H; Tamaya T
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):133-40. PubMed ID: 12710996
[TBL] [Abstract][Full Text] [Related]
18. The truncated estrogen receptor alpha variant lacking exon 5 is not involved in progesterone receptor expression in meningiomas.
Jacobs HM; van Spriel AB; Koehorst SG; Thijssen JH; Blaauw G; Blankenstein MA
J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):167-72. PubMed ID: 10704905
[TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex.
Perlman WR; Matsumoto M; Beltaifa S; Hyde TM; Saunders RC; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
Neuroscience; 2005; 134(1):81-95. PubMed ID: 15964702
[TBL] [Abstract][Full Text] [Related]
20. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
